Article info

other Versions

Download PDFPDF
Cytoreductive surgery followed by chemotherapy and olaparib maintenance in BRCA 1/2 mutated recurrent ovarian cancer: a retrospective MITO group study

Authors

  1. Correspondence to Professor Sandro Pignata, Gynecological Oncology, National Cancer Institute, Naples, Italy; s.pignata{at}istitutotumori.na.it
View Full Text

Citation

Cecere SC, Musacchio L, Bartoletti M, et al
Cytoreductive surgery followed by chemotherapy and olaparib maintenance in BRCA 1/2 mutated recurrent ovarian cancer: a retrospective MITO group study

Publication history

  • Received December 21, 2020
  • Revision received April 6, 2021
  • Accepted April 8, 2021
  • First published May 14, 2021.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.